- Redfund Capital’s 2018 portfolio consists of five companies; a total of 11 companies are in the pipeline at various due diligence stages
- New partnership was announced at the end of November for the purpose of developing water-soluble cannabis technologies
- During 2019, Redfund intends to maintain its CBD industry focus
The year of 2018 featured a number of important developments for Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4), the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility.
At the end of November, the company announced a key partnership with Cannabis Strategic Ventures (OTC: NUGS) for the development of water-soluble cannabis technologies to be used in the food and beverage industry, via Redfund-owned Biolog Inc. (http://cnw.fm/8xEXE).
According to representatives of Redfund and Cannabis Strategic Ventures, water-soluble cannabis technologies provide new opportunities for growth in the world of CBD products. Current water-soluble cannabis technologies come with specific limitations that stand in the way of adoption. Hence, Redfund and Cannabis Strategic Ventures will seek alternatives that enable the technology to push past original constraints for the purpose of developing cannabis ingredients for ready addition to foods, beverages and cosmetic products, to name a few.
Redfund has also partnered with Mary’s Wellness Ltd., a marketer and distributor of cannabis-infused teas (http://cnw.fm/t6FKa), and it is currently having active discussions with partners in the UK, Switzerland, Colombia and Portugal to help launch Mary’s products.
Additionally, the company is funding Winterlife Inc. as the latter launches a new CBD product line (http://cnw.fm/0koHS). Winterlife products are currently available in over 600 dispensaries throughout the State of Washington, with processing agreements in place with several other U.S. states.
In November, Redfund shared a comprehensive list of 2018 updates. According to the announcement, the core component of Redfund’s business strategy through the year was to establish the foundations of a loan portfolio that generates revenue with monthly interest income and that also grows value for shareholders (http://cnw.fm/4u1aG).
In 2018, the company extended funds for five signed promissory notes. In addition, Redfund had 11 companies in the pipeline at various stages of due diligence. As of November, the Redfund loan portfolio consists of Winterlife, Mary’s Wellness, RxMM Health Care, Biominerales Pharma Colombia and Biolog Inc.
Based on its strategy, Redfund aims to provide debt and equity funding in the mid and later stages of the development of a target company. The current focus is medical cannabis, hemp and CBD-related health care/wellness companies.
Redfund also launched an array of innovative initiatives throughout the year. First Euro Cannabis is one such initiative. A Redfund subsidiary, First Euro Cannabis is the first incubator and accelerator in Europe that finances medical cannabis, CBD and hemp companies. This subsidiary is also expected to play a major role in the European distribution of Winterlife products (http://cnw.fm/Oe1G1).
In terms of future development, Redfund has made some announcements about the growth anticipated in 2019.
Two of the companies in the Redfund portfolio are investigating the process for filing to the Canadian Securities Exchange. By the end of the first quarter of 2019, these companies anticipate becoming stand-alone public entities.
“The Company vision is to have a portfolio of 20 companies with $75 million injected through loans deployed to companies who have commonalities of revenues, brand awareness, and a keen interest to go global with their products… We are looking forward to our portfolio companies being leaders in the public markets,” Redfund CEO Meris Kott said in a news release.
For more information, visit the company’s website at www.RedfundCapital.com
More from CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
CannabisNewsWire is at the epicenter of the Cannabis Revolution.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CannabisNewsWire.com